The lesson of ivermectin: meta-analyses based on summary data alone are inherently unreliable
- PMID: 34552263
- DOI: 10.1038/s41591-021-01535-y
The lesson of ivermectin: meta-analyses based on summary data alone are inherently unreliable
Comment in
-
Meta-analyses based on summary data can provide timely, thorough and reliable evidence: don't dismiss them yet.Nat Med. 2022 Mar;28(3):429-430. doi: 10.1038/s41591-021-01675-1. Nat Med. 2022. PMID: 35145306 No abstract available.
Similar articles
-
Ivermectin in COVID-19: What do we know?Diabetes Metab Syndr. 2020 Nov-Dec;14(6):1921-1922. doi: 10.1016/j.dsx.2020.09.027. Epub 2020 Sep 28. Diabetes Metab Syndr. 2020. PMID: 33032231 Free PMC article. Review. No abstract available.
-
Pharmacokinetic considerations on the repurposing of ivermectin for treatment of COVID-19.Br J Clin Pharmacol. 2021 Mar;87(3):1589-1590. doi: 10.1111/bcp.14476. Epub 2020 Jul 17. Br J Clin Pharmacol. 2021. PMID: 32779815 Free PMC article. No abstract available.
-
Ivermectin in dermatology: why it 'mite' be useless against COVID-19.Clin Exp Dermatol. 2021 Oct;46(7):1327-1328. doi: 10.1111/ced.14704. Epub 2021 Jun 26. Clin Exp Dermatol. 2021. PMID: 33896010 Free PMC article. No abstract available.
-
Update to living WHO guideline on drugs for covid-19.BMJ. 2021 Mar 31;372:n860. doi: 10.1136/bmj.n860. BMJ. 2021. PMID: 33789884 No abstract available.
-
Pandemic and promise: progress towards finding an effective treatment for Novel Coronavirus 19.Aust N Z J Public Health. 2020 Dec;44(6):437-439. doi: 10.1111/1753-6405.13044. Epub 2020 Oct 12. Aust N Z J Public Health. 2020. PMID: 33044799 Free PMC article. Review. No abstract available.
Cited by
-
Expression of Concern for Kory P, Meduri GU, Varon J, Iglesias J, Marik PE. Review of the Emerging Evidence Demonstrating the Efficacy of Ivermectin in the Prophylaxis and Treatment of COVID-19. Am J Ther. 2021;28(3): e299-e318.Am J Ther. 2022 Feb 14;29(2):e231. doi: 10.1097/MJT.0000000000001481. Am J Ther. 2022. PMID: 35142703 Free PMC article. No abstract available.
-
Methodological information extraction from randomized controlled trial publications: a pilot study.AMIA Annu Symp Proc. 2023 Apr 29;2022:542-551. eCollection 2022. AMIA Annu Symp Proc. 2023. PMID: 37128457 Free PMC article. Clinical Trial.
-
Towards replicability and sustainability in cancer research.BJC Rep. 2024 Sep 4;2(1):65. doi: 10.1038/s44276-024-00090-6. BJC Rep. 2024. PMID: 39516681 Free PMC article. Review.
-
Signals were broadly positive for months, but never definitive: the tocilizumab story.Clin Microbiol Infect. 2022 Mar;28(3):371-374. doi: 10.1016/j.cmi.2021.10.018. Epub 2021 Nov 9. Clin Microbiol Infect. 2022. PMID: 34768021 Free PMC article. Review.
-
How to modernize medical evidence for the misinformation era.Nat Med. 2023 Oct;29(10):2383-2386. doi: 10.1038/s41591-023-02537-8. Nat Med. 2023. PMID: 37794251 No abstract available.
References
-
- Elgazzar, A. et al. Preprint at https://www.researchsquare.com/article/rs-100956/v3 (2020).
-
- Bryant, A. et al. Am. J. Ther. 28, e434–e460 (2021). - DOI
-
- Hill, A. et al. Open Forum Infectious Diseases https://doi.org/10.1093/ofid/ofab358 (2021).
-
- Davey, M. The Guardian https://www.theguardian.com/science/2021/jul/16/huge-study-supporting-iv... (16 July 2021).
-
- Elgazzar, A. et al. Preprint at https://doi.org/10.21203/rs.3.rs-100956/v2 (2020).
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
